Esseliv Duo is a dietary supplement designed to be used to maintain a healthy liver and normal digestive processes.
Allergic to any component of the product. Consult a doctor before using the product during pregnancy and breast-feeding.
Esseliv Duo owes its positive effect on liver function and digestion to the content of active ingredients. Extract from turmeric (Curcuma longa) inhibits the accumulation of fat and helps maintain a healthy liver. Supports digestion and proper functioning of the liver. Rapeseed lecithin contains compounds from the group of phospholipids. Phospholipids are natural structural elements of cell membranes. L-ornithine L-aspartate is a combination of two endogenous amino acids: ornithine and aspartic acid. In the human body it performs numerous physiological functions. Niacin, vitamin B6 and folic acid, in turn, in the Esseliv Duo preparation supplement the diet with B group vitamins. Niacin and vitamin B6 additionally contribute to maintaining normal protein and glycogen metabolism. Folic acid contained in the preparation belongs to folates, which are involved in the process of cell division. Esseliv Duo is recommended for people whose liver is exposed to adverse external factors such as incorrect or difficult to digest diet, alcohol, medicines and to supplement the diet with B group vitamins.
Esselivu Duo ingredients: L-ornithine L-aspartate, rapeseed lecithin, turmeric extract, talc (bulking agent), magnesium salts of fatty acids (glazing agent), nicotinic acid amide, silicon dioxide (anti-caking agent), pyridoxyl hydrochloride, pyridoxyl hydrochloride . Capsule ingredients: gelatin, titanium dioxide (dye).
The recommended daily dose of Esselivu Duo for adults is 2 capsules.
Dietary supplements cannot be used as a substitute for a varied diet or a healthy lifestyle. Do not exceed recommended servings for consumption during the day. Dietary supplements should be stored out of reach of small children. Before using the product, we suggest that you read the exact information on the packaging or the attached leaflet."